About Careers MedBlog Contact us

Maharashtra FDA Takes Complan to Court Over “Tall” Claims

by Kathy Jones on July 9, 2010 at 10:49 PM
Font : A-A+

 Maharashtra FDA Takes Complan to Court Over “Tall” Claims

The Maharashtra Food and Drug Administration (FDA) has taken Heinz India to court over claims that drinking Complan will add two inches to a child's height.

The move was initiated by pediatrician Dr R K Anand, who along with the Association for Consumers' Action on Safety & Health (ACASH) studied the claims of the company. Doctors from the Indian Academy of Pediatrics were also roped in to study the veracity of Complan's research paper.


"We moved the FDA in November 2009 with our case, stating that there was a clear violation of the Prevention of Food Adulteration Act," said Anand.

The FDA has chargesheeted seven officials of Heinz India Pvt Ltd. Their offence is described as "an exaggerated advertisement on television channels about food article Complan".

Heinz India denied any knowledge of the case, "We are not aware of any such complaint having been filed. We stand by our claim and would defend the same with appropriate research study," the company said.

Source: Medindia


Latest General Health News

What Are the Consequences of Celebrities Endorsing Tobacco?
In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.
 People Living Close to the Seaside Enjoy Better Health
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
 Over Four Million Gardeners Place Their Hearing in Danger
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Breaking the Barrier: Unraveling Mucus Plugs to Save Lives in COPD
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
 Disease Modifying Therapies for Multiple Sclerosis Continue to Drive Up Healthcare Cost
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Maharashtra FDA Takes Complan to Court Over “Tall” Claims Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests